Mercy has earned the NRC Health 2026 Excellence in Patient Experience Award for the fifth consecutive year, distinguishing it as one of only three large U.S. health systems to receive this honor. The award is based on patient feedback and their willingness to recommend Mercy, reflecting the system's commitment to compassionate, high-quality care across its hospitals and clinics. Mercy serves millions annually with over 50,000 caregivers and actively uses patient feedback from more than 1.25 million encounters each year to improve care. This recognition highlights Mercy's leadership in patient experience and its ongoing dedication to listening and responding to patient needs.
Bunzl PLC reported stronger-than-expected financial results with an EPS of $0.60, surpassing the $0.56 consensus. Revenue reached $8.04 billion, driven by a 3.2% underlying growth, especially in North America. The operating margin improved to 7.3%, p...
Palo Alto Networks is set to report strong earnings per share (EPS) of $0.98 and revenue of $3.35 billion for the upcoming quarter, reflecting significant growth from last year. Investor optimism is driven by robust cybersecurity sector trends and a ...
Medtronic reported Q3 earnings per share of $1.45, surpassing estimates of $1.39, and revenue of $9.76 billion, above the $9.55 billion consensus. The strong financial results reflect broad demand for its cardiovascular devices. The company raised it...
Dell Technologies is expected to report record second-quarter earnings with EPS around $4.91 and revenue near $44.89 billion, fueled by high demand for its AI-optimized servers. This would mark a significant increase from last year's $29.78 billion a...
Protagonist Therapeutics saw its stock price target raised to $180 by Barclays following the FDA approval of MIMRYLO, a first-in-class drug for polycythemia vera. The approval was based on strong Phase 3 trial results with 76.9% patient response, tri...
